Today, GBA Group announces that Eureka Analytical Services Pvt Ltd (Eureka) is now an official member of GBA Group. GBA Group’s entry into the Indian market is a key element of its growth strategy, as India’s rapid, dynamic and future-oriented […]
Author: Firma GBA GROUP
GBA Medical Device Services lays “foundation stone” for further growth at new location in Gilching
Posted on Posted in General
GBA Medical Device Services GmbH (GBA MDS) has signed a long-term rental agreement for its new company headquarters. A state-of-the-art LEAN-optimized laboratory is being built close to the current site, which will bring a fourfold increase in capacity compared to […]
GBA Group expands range of toxicology services
Posted on Posted in General
GBA Group is expanding its range of toxicology services for customers in the chemical, medical device and pharmaceutical industries with the acquisition of ICCR-Roßdorf GmbH (ICCR-Roßdorf). This acquisition underlines GBA Group’s ambition to position itself broadly as an international life […]
GBA Group continues to expand network in Finland
Posted on Posted in General
With the acquisition of the Finnish company Tampereen asbesti- ja kuitulaboratorio Oy (Taklab) by Labroc Oy (Labroc), GBA Group continues to expand its European network in the field of laboratory analysis for building pollutants. The merger marks an important milestone […]
GBA Group expands to U.S. market
Posted on Posted in General
GBA Group, a leading European life science service provider, enters the U.S. market with a site in Westborough, Massachusetts to support clinical trials. Located in the greater Boston area, a pharmaceutical and biotech hub, the laboratory and logistics site will […]
Dr. Birgit Schumacher elected to Executive Committee of VUP
Posted on Posted in General
Last Friday, the members of the VUP (German Association of Independent Testing Laboratories) elected Dr. Birgit Schumacher, Managing Director of GBA Pharma GmbH, as a new member of its Executive Committee. In this function, she will actively shape the future […]
GBA Group bundles broader range of offerings in new Life Sciences division
Posted on Posted in General
In recent months, GBA Group has significantly expanded its service portfolio for customers in the pharmaceutical, medical device, cosmetics and agrochemical industries. Against this backdrop, the activities in this area will be combined in the new Life Sciences division in […]
Market entry into France: GBA Group expands European pharmaceutical and Life Science network
Posted on Posted in General
With the acquisition of the French company KaLy-Cell SAS (KaLy-Cell), GBA Group expands its European pharmaceutical network. This is an important milestone for the GBA Group to offer a comprehensive service portfolio for national and international customers along the development […]
GBA Group expands range of services in the field of biological safety of medical devices
Posted on Posted in General
Medical Device Services – Dr. Rossberger GmbH (MDS) – (in future: GBA Medical Device Services GmbH) becomes part of the GBA Group laboratory network. With this acquisition, GBA Group has significantly expanded its service portfolio in the field of medical […]
New Managing Director at GBA Group: Dr. Sabine Gorynia takes over responsibility for the Pharmaceuticals business unit as of July 1st, 2022
Posted on Posted in General
GBA Group Pharma has been under new management since July 1st. Dr. Sabine Gorynia joins GBA Holding GmbH as Managing Director and thus complements the GBA Group management team in an important position. Dr. Gorynia brings decisive qualifications to her […]